Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Long Peng

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Chemsuschem|December 4, 2025
Geometry Engineering of V/Y/X-Shaped Nonfullerene Acceptors for Ternary Organic PhotovoltaicsYu-Long Peng, Peng Liu, Pachaiyappan Murugan, et al.
Phytochemistry|February 14, 2022
Decalintetracids A and B, two pairs of unusual 3-decalinoyltetramic acid derivatives with phytotoxicity from Fusarium equiseti D39Dong-Lin Zhao, Jing Liu, Xiao-Bin Han, et al.
Chemistry, an Asian Journal|January 14, 2026
Facile Access to IDT-Based Acceptor via Direct C-H Arylation and Its Exploration in Binary and Ternary Organic Solar CellsYu-Long Peng, Zhi-Yong Qiu, Peng Liu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 17, 2004
[Treatment of lymphoma patients with fludarabine-based regimens: a report of 29 cases]Hui-Qiang Huang, Wen-Qi Jiang, Yu-Long Peng, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|August 11, 2004
[Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen]Yu-Long Peng, Hui-Qiang Huang, Xu-Bin Lin, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 15, 2005
[Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases]Zhan-He Pan, Hui-Qiang Huang, Xu-Bin Lin, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|November 30, 2004
[Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen]Hui-Qiang Huang, Yu-Long Peng, Xu-Bin Lin, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 15, 2006
[Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]Hui-Qiang Huang, Qing Bu, Zhong-Jun Xia, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 15, 2006
[Long-term outcomes of 392 non-Hodgkin's lymphoma patients treated with pirarubicin based regimens]Hui-Qiang Huang, Yu-Long Peng, Qing-Qing Cai, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Chemsuschem|December 4, 2025
Geometry Engineering of V/Y/X-Shaped Nonfullerene Acceptors for Ternary Organic PhotovoltaicsYu-Long Peng, Peng Liu, Pachaiyappan Murugan, et al.
Phytochemistry|February 14, 2022
Decalintetracids A and B, two pairs of unusual 3-decalinoyltetramic acid derivatives with phytotoxicity from Fusarium equiseti D39Dong-Lin Zhao, Jing Liu, Xiao-Bin Han, et al.
Chemistry, an Asian Journal|January 14, 2026
Facile Access to IDT-Based Acceptor via Direct C-H Arylation and Its Exploration in Binary and Ternary Organic Solar CellsYu-Long Peng, Zhi-Yong Qiu, Peng Liu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 17, 2004
[Treatment of lymphoma patients with fludarabine-based regimens: a report of 29 cases]Hui-Qiang Huang, Wen-Qi Jiang, Yu-Long Peng, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|August 11, 2004
[Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen]Yu-Long Peng, Hui-Qiang Huang, Xu-Bin Lin, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 15, 2005
[Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases]Zhan-He Pan, Hui-Qiang Huang, Xu-Bin Lin, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|November 30, 2004
[Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen]Hui-Qiang Huang, Yu-Long Peng, Xu-Bin Lin, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 15, 2006
[Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]Hui-Qiang Huang, Qing Bu, Zhong-Jun Xia, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 15, 2006
[Long-term outcomes of 392 non-Hodgkin's lymphoma patients treated with pirarubicin based regimens]Hui-Qiang Huang, Yu-Long Peng, Qing-Qing Cai, et al.
Pageof 2